Detected ·
PANDA Therapeutics
CHF 150K—
PANDA Therapeutics received CHF 150,000 from Venture Kick (Stage III funding) to advance its multi-target, antibody-based Alzheimer’s therapy targeting amyloid-beta and tau.
- Website
- —
- —
- Amount
- CHF 150 000 CHF
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-01 04:06:49 UTC
- Signal ID
- 40728f67-8dd7-433c-8b0d-f6bebb437674
As the API returns it
{
"id": "40728f67-8dd7-433c-8b0d-f6bebb437674",
"created_at": "2026-09-01T04:06:49.763133Z",
"company_name": "PANDA Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 150000,
"funding_currency": "CHF",
"funding_stage": null,
"message": "*PANDA Therapeutics received CHF 150,000 from Venture Kick (Stage III funding) to advance its multi-target, antibody-based Alzheimer’s therapy targeting amyloid-beta and tau.*"
}